BMY vs RVTY
Bristol Myers Squibb vs Revvity — AI-powered side-by-side comparison
| Metric | BMY | RVTY |
|---|---|---|
| AI Score | 61 | 71 |
| Price | $63.63 | $115.05 |
| P/E Ratio | 14.51× | 52.97× |
| ROE | 38.2% | 3.3% |
| Revenue Growth YoY | — | — |
| Gross Margin | 70.2% | 52.1% |
| Debt / Equity | 1.93× | 0.46× |
| Dividend Yield | 3.8% | 0.3% |
| RSI (14) | 81.8 | 48.6 |
| Beta | 0.235 | 1.072 |
| Expected Upside | +0.5% | +4.3% |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
BMY Full Analysis
RVTY Full Analysis